These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Review article: diabetes and atherosclerosis--running on a common road. Federici M; Lauro R Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():11-5. PubMed ID: 16225464 [TBL] [Abstract][Full Text] [Related]
7. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium. Nathanson D; Nyström T Mol Cell Endocrinol; 2009 Jan; 297(1-2):112-26. PubMed ID: 19038307 [TBL] [Abstract][Full Text] [Related]
8. Impaired endothelial function and insulin action in first-degree relatives of patients with type 2 diabetes mellitus. Sonne MP; Højbjerre L; Alibegovic AA; Vaag A; Stallknecht B; Dela F Metabolism; 2009 Jan; 58(1):93-101. PubMed ID: 19059536 [TBL] [Abstract][Full Text] [Related]
9. Family history of diabetes is a major determinant of endothelial function. Goldfine AB; Beckman JA; Betensky RA; Devlin H; Hurley S; Varo N; Schonbeck U; Patti ME; Creager MA J Am Coll Cardiol; 2006 Jun; 47(12):2456-61. PubMed ID: 16781373 [TBL] [Abstract][Full Text] [Related]
11. Role of insulin resistance and hyperglycemia in the development of atherosclerosis. Bansilal S; Farkouh ME; Fuster V Am J Cardiol; 2007 Feb; 99(4A):6B-14B. PubMed ID: 17307054 [TBL] [Abstract][Full Text] [Related]
12. Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus. Guerci B; Böhme P; Kearney-Schwartz A; Zannad F; Drouin P Diabetes Metab; 2001 Sep; 27(4 Pt 1):436-47. PubMed ID: 11547217 [TBL] [Abstract][Full Text] [Related]
13. Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity. Bakker W; Eringa EC; Sipkema P; van Hinsbergh VW Cell Tissue Res; 2009 Jan; 335(1):165-89. PubMed ID: 18941783 [TBL] [Abstract][Full Text] [Related]
14. Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease. Caballero AE Obes Res; 2003 Nov; 11(11):1278-89. PubMed ID: 14627747 [TBL] [Abstract][Full Text] [Related]
15. Acute hyperglycemia and hyperinsulinemia enhance vasodilatation in Type 1 diabetes mellitus without increasing capillary permeability and inducing endothelial dysfunction. Oomen PH; Kant GD; Dullaart RP; Reitsma WD; Smit AJ Microvasc Res; 2002 Jan; 63(1):1-9. PubMed ID: 11749067 [TBL] [Abstract][Full Text] [Related]
16. Hyperglycemia and hyperlipidemia are associated with endothelial dysfunction during the development of type 2 diabetes. Okon EB; Chung AW; Zhang H; Laher I; van Breemen C Can J Physiol Pharmacol; 2007 May; 85(5):562-7. PubMed ID: 17632592 [TBL] [Abstract][Full Text] [Related]
17. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes? Corbould A Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869 [TBL] [Abstract][Full Text] [Related]
18. Thiazolidinediones-improving endothelial function and potential long-term benefits on cardiovascular disease in subjects with type 2 diabetes. Dandona P; Ghanim H; Chaudhuri A; Mohanty P J Diabetes Complications; 2008; 22(1):62-75. PubMed ID: 18191079 [TBL] [Abstract][Full Text] [Related]